The Effects of oil-in-Water Nanoemulsion Polyethylene Glycol Surface Density on Intracellular Stability, Pharmacokinetics, and Biodistribution in Tumor Bearing Mice

[1]  K. Ulbrich,et al.  Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes. , 2014, ACS nano.

[2]  David Izquierdo-Garcia,et al.  A Statin-Loaded Reconstituted High-Density Lipoprotein Nanoparticle Inhibits Atherosclerotic Plaque Inflammation , 2014, Nature Communications.

[3]  R. Jain,et al.  Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. , 2013, Cancer research.

[4]  S. Kulkarni,et al.  Effects of Particle Size and Surface Modification on Cellular Uptake and Biodistribution of Polymeric Nanoparticles for Drug Delivery , 2013, Pharmaceutical Research.

[5]  Olav Haraldseth,et al.  The effect of nanoparticle polyethylene glycol surface density on ligand-directed tumor targeting studied in vivo by dual modality imaging. , 2012, ACS nano.

[6]  Claudia Calcagno,et al.  Multifunctional nanoemulsion platform for imaging guided therapy evaluated in experimental cancer. , 2011, ACS nano.

[7]  Claudia Calcagno,et al.  A versatile and tunable coating strategy allows control of nanocrystal delivery to cell types in the liver. , 2011, Bioconjugate chemistry.

[8]  J Szebeni,et al.  Complement activation cascade triggered by PEG-PL engineered nanomedicines and carbon nanotubes: the challenges ahead. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[9]  S. Caruthers,et al.  Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions , 2010, Angiogenesis.

[10]  Zahi A Fayad,et al.  Iron oxide core oil-in-water emulsions as a multifunctional nanoparticle platform for tumor targeting and imaging. , 2009, Biomaterials.

[11]  Peter Wipf,et al.  Nanoparticles in cellular drug delivery. , 2009, Bioorganic & medicinal chemistry.

[12]  Robert Langer,et al.  PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. , 2009, Biomaterials.

[13]  S. Moghimi,et al.  Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process. , 2008, Molecular immunology.

[14]  John W. Park,et al.  Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development. , 2008, Journal of pharmaceutical sciences.

[15]  Thomas D. Dziubla,et al.  PEGylation of nanocarrier drug delivery systems: State of the art , 2008 .

[16]  David J Brayden,et al.  Advances in PEGylation of important biotech molecules: delivery aspects , 2008, Expert opinion on drug delivery.

[17]  G. Kenner,et al.  Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding. , 2007, Biochimica et biophysica acta.

[18]  Janos Szebeni,et al.  Methylation of the phosphate oxygen moiety of phospholipid‐methoxy(polyethylene glycol) conjugate prevents PEGylated liposome‐mediated complement activation and anaphylatoxin production , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  F. Cordelières,et al.  A guided tour into subcellular colocalization analysis in light microscopy , 2006, Journal of microscopy.

[20]  Volker Wagner,et al.  The emerging nanomedicine landscape , 2006, Nature Biotechnology.

[21]  Janos Szebeni,et al.  Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity. , 2005, Toxicology.

[22]  Y. Barenholz,et al.  Electrostatics of PEGylated micelles and liposomes containing charged and neutral lipopolymers. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[23]  K. Edwards,et al.  Liposomes, disks, and spherical micelles: aggregate structure in mixtures of gel phase phosphatidylcholines and poly(ethylene glycol)-phospholipids. , 2003, Biophysical journal.

[24]  Vincent Noireaux,et al.  In Vivo Imaging of Quantum Dots Encapsulated in Phospholipid Micelles , 2002, Science.

[25]  John D Lambris,et al.  Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. , 2002, Blood.

[26]  R. Schiffelers,et al.  Localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue: influence of liposome characteristics. , 1999, Biochimica et biophysica acta.

[27]  R. Gillies,et al.  Causes and effects of heterogeneous perfusion in tumors. , 1999, Neoplasia.

[28]  Feng Liu,et al.  Long-Circulating Emulsions (Oil-in-Water) as Carriers for Lipophilic Drugs , 1995, Pharmaceutical Research.

[29]  T. Allen.  Long-circulating (sterically stabilized) liposomes for targeted drug delivery. , 1994, Trends in pharmacological sciences.

[30]  D Needham,et al.  Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue. , 1993, Cancer research.

[31]  G Blume,et al.  Molecular mechanism of the lipid vesicle longevity in vivo. , 1993, Biochimica et biophysica acta.

[32]  A. Gabizon,et al.  Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[33]  T. Allen,et al.  Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size. , 1991, Biochimica et biophysica acta.

[34]  Kazuo Maruyama,et al.  Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.

[35]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[36]  J. M. Harris,et al.  Pegylation: a novel process for modifying pharmacokinetics. , 2001, Clinical pharmacokinetics.

[37]  L. Seymour.  Passive tumor targeting of soluble macromolecules and drug conjugates. , 1992, Critical reviews in therapeutic drug carrier systems.

[38]  R. Jain,et al.  Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. , 1991, Cancer research.

[39]  A. Bøyum,et al.  Separation of leukocytes from blood and bone marrow. Introduction. , 1968 .

[40]  T. Henriksen.  Energy transfer and radioprotection in biological systems. , 1968, Scandinavian journal of clinical and laboratory investigation. Supplementum.